Related Experiment Videos
Nociception, pain, and antinociception: current concepts
1Max-Planck-Institut für Physiologische und Klinische Forschung W.-G.-Kerckhoff-Institut Parkstrasse 1, 61231 Bad Nauheim, Germany.
Zeitschrift Fur Rheumatologie
|February 6, 2002
Summary
Chronic pain involves altered nociception pathways. The N-methyl-D-aspartate (NMDA) and opioid systems modulate pain, with nitric oxide (NO) playing a key role in hyperalgesia.
Area of Science:
- Neuroscience
- Pain Research
- Physiology
Background:
- Nociception is a complex process involving peripheral and central nervous system (CNS) structures.
- Chronic pain pathophysiology involves alterations leading to hyperalgesia or allodynia.
- Nociceptive information is processed through the spinal cord, thalamus, and somatosensory cortex.
Purpose of the Study:
- To explore the modulatory mechanisms of nociception and antinociception within the CNS.
- To investigate the roles of the N-methyl-D-aspartate (NMDA) and opioid receptor systems in pain.
- To understand the contribution of nitric oxide (NO) in pain pathways.
Main Methods:
- Review of physiological and pathophysiological pathways of nociception.
- Analysis of the interaction between NMDA and opioid receptor systems.
- Examination of the role of glutamate, nitric oxide synthase (NOS), and nitric oxide (NO) in pain signaling.
Main Results:
- NMDA receptor activation contributes to hyperalgesia, facilitated by glutamate.
- Nitric oxide (NO), produced via NMDA receptor stimulation, can lead to hyperexcitability and pain.
- Opioid receptor subtypes differentially modulate NMDA receptor activity; CRH shows analgesic effects.
Conclusions:
- Nociception is modulated at all levels of the neuraxis.
- The interplay between NMDA and opioid systems is crucial for pain modulation.
- Understanding these pathways is key to addressing the multidimensional experience of pain.